Efficacy of camostat mesilate against dyspepsia associated with non-alcoholic mild pancreatic disease

Journal of Gastroenterology

Volumn 45, Issue 3, 2010, Pages 335-341

  Sai, Jin Kan ^a   Suyama, Masafumi ^a   Kubokawa, Yoshihiro ^a   Matsumura, Yuji ^a   Inami, Koichi ^a   Watanabe, Sumio ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Camostat mesilate; Dyspepsia; Mild chronic pancreatitis

Indexed keywords

ALCOHOL; AMYLASE; CAMOSTAT MESILATE; TRIACYLGLYCEROL LIPASE;

ADULT; ALCOHOL CONSUMPTION; AMYLASE BLOOD LEVEL; ARTICLE; CHRONIC PANCREATITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DYSPEPSIA; ENDOSCOPIC ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; UPPER ABDOMINAL PAIN;

ABDOMINAL PAIN; ADULT; AGED; DYSPEPSIA; ENDOSONOGRAPHY; FEMALE; GABEXATE; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PANCREATIC DISEASES; PROSPECTIVE STUDIES; PROTEASE INHIBITORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77950460130     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-009-0148-1     Document Type: Article

References (31)

1. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut. 1999;45(Suppl. 2):II37-42.
2. El-Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther. 2004;19:643-654
3. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466-1479
4. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenteology. 2006;130:1377-1390
5. Sahai AV, Mishra G, Penman ID, Williams D, Wallace MB, Hadzijahic N, et al. EUS to detect evidence of pancreatic disease in patients with persistent or nonspecific dyspepsia. Gastrointest Endosc. 2000;52:153-159
6. DeWitt J, McGreevy K, LeBlanc J, McHenry L, Cummings O, Sherman S. EUS-guided Trucut biopsy of suspected nonfocal chronic pancreatitis. Gastrointest Endosc. 2005;62:76-84.
7. Chong AK, Hawes RH, Hoffman BJ, Adams DB, Lewin DN, Romagnuolo J. Diagnostic performance of EUS for chronic pancreatitis: a comparison with histopathology. Gastrointest En-dosc. 2007;65:808-814
8. Otsuki M, Tani S, Okabayashi Y, Fuji M, Nakamura T, Fujisawa T, et al. Beneficial effects of the synthetic trypsin inhibitor camostat in cerulein-induced acute pancreatitis in rats. Dig Dis Sci. 1990;35:242-250
9. Gibo J, Ito T, Kawabe K, Hisano T, Inoue M, Fujimori N, et al. Camostat mesilate attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity. Lab Invest. 2005;85:75-89.
10. Emori Y, Mizushima T, Matsumura N, Ochi K, Tanioka H, Shirahige A, et al. Camostat, an oral trypsin inhibitor, reduces pancreatic fibrosis induced by repeated administration of a superoxide dismutase inhibitor in rats. J Gastroenterol Hepatol. 2005;20:895-899
11. Ashizawa N, Hashimoto T, Miyake T, Shizuku T, Imaoka T, Kinoshita Y. Efficacy of camostat mesilate compared with famotidine for treatment of functional dyspepsia: is camostat mesilate effective? J Gastroenterol Hepatol. 2006;21:767-771
12. Sahai AV, Zimmerman M, Aabakken L, Tarnasky PR, Cunningham JT, van Velse A, et al. Prospective assessment of the ability of endoscopic ultrasound to diagnose, exclude, or establish the severity of chronic pancreatitis found by endoscopic retrograde cholangiopancreatography. Gastrointest Endosc. 1998;48:18-25.
13. Lees WR. Endoscopic ultrasonography of chronic pancreatitis and pancreatic pseudocysts. Scand J Gastroenterol Suppl. 1986;123:123-129
14. Zuccaro G Jr, Sivak MV Jr. Endoscopic ultrasonography in the diagnosis of chronic pancreatitis. Endoscopy. 1992;24:347-349
15. Wiersema MJ, Hawes RH, Lehman GA, Kochman ML, Sherman S, Kopecky KK. Prospective evaluation of endoscopic ultraso-nography and endoscopic retrograde cholangiopancreatography in patients with chronic abdominal pain of suspected pancreatic origin. Endoscopy. 1993;25:555-564
16. Varadarajulu S, Eltoum I, Tamhane A, Eloubeidi MA. Histo-pathologic correlates of noncalcific chronic pancreatitis by EUS: a prospective tissue characterization study. Gastrointest Endosc. 2007;66:501-509
17. Savides TJ, Gress FG, Zaidi SA, Ikenberry SO, Hawes RH. Detection of embryologic ventral pancreatic parenchyma with endoscopic ultrasound. Gastrointest Endosc. 1996;43:14-19
18. Talley NJ, Vakil N, Practice Parameters Committee of the American College of Gastroenterology. Guidelines for the management of dyspepsia. Am J Gastroenterol. 2005;100:2324-2337
19. Agreus L, Svardsudd K, Nyren O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology. 1995;109:671-680
20. Williams B, Luckas M, Ellingham JH, Dain A, Wicks AC. Do young patients with dyspepsia need investigation? Lancet. 1988;2(8624):1349-1351
21. Talley NJ, McNeil D,Hayden A,ColreavyC, Piper DW. Prognosis of chronic unexplained dyspepsia. A prospective study of potential predictor variables in patients with endoscopically diagnosed nonulcer dyspepsia. Gastroenterology. 1987;92:1060-1066
22. Forsmark CE. The diagnosis of chronic pancreatitis. Gastrointest Endosc. 2000;52:293-298
23. Bozkurt T, Braun U, Leferink S, Gilly G, Lux G. Comparison of pancreatic morphology and exocrine functional impairment in patients with chronic pancreatitis. Gut. 1994;35:1132-1136
24. Andersen BN, Scheel J, Rune SJ, Worning H. Exocrine pancreatic function in patients with dyspepsia. Hepatogastroenterology. 1982;29:35-37
25. Smith RC, Talley NJ, Dent OF, Jones M, Waller SL. Exocrine pancreatic function and chronic unexplained dyspepsia. A case-control study. Int J Pancreatol. 1991;8:253-262
26. Irisawa A, Mishra G, Hernandez LV, Bhutani MS. Quantitive analysis of endosonographic parenchymal echogenecity in patients with chronic pancreatitis. J Gastroenterol Hepatol. 2004; 19:1199-1205
27. Catalano MF, Lahoti S, Geenen JE, Hogan WJ. Prospective evaluation of endoscopic ultrasonography, endoscopic retrograde pancreatography, and secretin test in the diagnosis of chronic pancreatitis. Gastrointest Endosc. 1998;48:11-17 (Pubitemid 28337422)
28. Wallace MB, Hawes RH, Durkalski V, Chak A, Mallery S, Catalano MF, et al. The reliability of EUS for the diagnosis of chronic pancreatitis: interobserver agreement among experienced endosonographers. Gastrointest Endosc. 2001;53:294-299 (Pubitemid 32207312)
29. Catalano MF, Sahai A, Levy M, Romagnuolo J, Wiersema M, Brugge W, et al. EUS-based criteria for the diagnosis of chronic pancreatitis: the Rosemont classification. Gastrointest Endosc. 2009;69:1251-1261
30. Hirano K, Nakazawa S, Tomita T. Effects of gabexate, a protease inhibitor, on smooth muscle of guinea-pig stomach fundus. Pharmacol Toxicol. 1995;76:102-106
31. Ito T, Kamada T. Clinical research for new evidence of possible chronic pancreatitis (in Japanese). Shoukakika. 2003;36:515-522